Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.

Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A.

Cell. 2011 Feb 4;144(3):439-52. doi: 10.1016/j.cell.2010.12.032.

2.

A functionally characterized test set of human induced pluripotent stem cells.

Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ, Williams DJ, Kahler DJ, Yamaki M, Davidow L, Rodolfa CT, Dimos JT, Mikkilineni S, MacDermott AB, Woolf CJ, Henderson CE, Wichterle H, Eggan K.

Nat Biotechnol. 2011 Mar;29(3):279-86. doi: 10.1038/nbt.1783. Epub 2011 Feb 3.

3.

Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.

Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P, Carcenac R, Astord S, Pereira de Moura A, Voit T, Barkats M.

Hum Mol Genet. 2011 Feb 15;20(4):681-93. doi: 10.1093/hmg/ddq514. Epub 2010 Nov 30.

PMID:
21118896
4.

AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.

Dodge JC, Treleaven CM, Fidler JA, Hester M, Haidet A, Handy C, Rao M, Eagle A, Matthews JC, Taksir TV, Cheng SH, Shihabuddin LS, Kaspar BK.

Mol Ther. 2010 Dec;18(12):2075-84. doi: 10.1038/mt.2010.206. Epub 2010 Sep 21.

5.

Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord.

Rossi SL, Nistor G, Wyatt T, Yin HZ, Poole AJ, Weiss JH, Gardener MJ, Dijkstra S, Fischer DF, Keirstead HS.

PLoS One. 2010 Jul 29;5(7):e11852. doi: 10.1371/journal.pone.0011852.

6.

Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.

Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ, Azzouz M.

Sci Transl Med. 2010 Jun 9;2(35):35ra42. doi: 10.1126/scitranslmed.3000830.

7.

CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.

Passini MA, Bu J, Roskelley EM, Richards AM, Sardi SP, O'Riordan CR, Klinger KW, Shihabuddin LS, Cheng SH.

J Clin Invest. 2010 Apr;120(4):1253-64. doi: 10.1172/JCI41615. Epub 2010 Mar 15.

8.

Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.

Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AH, Kaspar BK.

Nat Biotechnol. 2010 Mar;28(3):271-4. doi: 10.1038/nbt.1610. Epub 2010 Feb 28.

9.

Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.

Aoki T, Ohnishi H, Oda Y, Tadokoro M, Sasao M, Kato H, Hattori K, Ohgushi H.

Tissue Eng Part A. 2010 Jul;16(7):2197-206. doi: 10.1089/ten.TEA.2009.0747.

PMID:
20146561
10.

Generation of induced pluripotent stem cells from neural stem cells.

Kim JB, Zaehres H, Araúzo-Bravo MJ, Schöler HR.

Nat Protoc. 2009;4(10):1464-70. doi: 10.1038/nprot.2009.173. Epub 2009 Sep 17.

PMID:
19798081
11.

Generation of induced pluripotent stem cells from human cord blood.

Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, Zweigerdt R, Gruh I, Meyer J, Wagner S, Maier LS, Han DW, Glage S, Miller K, Fischer P, Schöler HR, Martin U.

Cell Stem Cell. 2009 Oct 2;5(4):434-41. doi: 10.1016/j.stem.2009.08.021.

12.

Two factor reprogramming of human neural stem cells into pluripotency.

Hester ME, Song S, Miranda CJ, Eagle A, Schwartz PH, Kaspar BK.

PLoS One. 2009 Sep 18;4(9):e7044. doi: 10.1371/journal.pone.0007044.

13.

Direct reprogramming of human neural stem cells by OCT4.

Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.

Nature. 2009 Oct 1;461(7264):649-3. doi: 10.1038/nature08436.

PMID:
19718018
14.

Differentiation of spinal motor neurons from pluripotent human stem cells.

Hu BY, Zhang SC.

Nat Protoc. 2009;4(9):1295-304. doi: 10.1038/nprot.2009.127. Epub 2009 Aug 20.

15.

Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Friling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E, Alekseenko Z, Marklund U, Kjellander S, Volakakis N, Hovatta O, El Manira A, Björklund A, Perlmann T, Ericson J.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7613-8. doi: 10.1073/pnas.0902396106. Epub 2009 Apr 21. Erratum in: Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21229.

16.

Virus-free induction of pluripotency and subsequent excision of reprogramming factors.

Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K.

Nature. 2009 Apr 9;458(7239):771-5. doi: 10.1038/nature07864. Epub 2009 Mar 1.

17.

Induced pluripotent stem cells from a spinal muscular atrophy patient.

Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN.

Nature. 2009 Jan 15;457(7227):277-80. doi: 10.1038/nature07677. Epub 2008 Dec 21.

18.

Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells.

Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH.

Cell Stem Cell. 2008 Dec 4;3(6):649-57. doi: 10.1016/j.stem.2008.10.001.

19.

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation.

Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC.

Cell Stem Cell. 2008 Dec 4;3(6):637-48. doi: 10.1016/j.stem.2008.09.017.

20.

Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.

Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, Ronchi D, Saladino F, Bordoni A, Fortunato F, Del Bo R, Papadimitriou D, Locatelli F, Menozzi G, Strazzer S, Bresolin N, Comi GP.

J Clin Invest. 2008 Oct;118(10):3316-30. doi: 10.1172/JCI35432.

Supplemental Content

Support Center